INTRODUCTION
Birds given a live coccidiosis vaccine often show signs of diminished appetite and slower-than-expected growth following vaccination. Historically, conventional broiler management has alleviated the symptoms by supplementing the flock with sub-therapeutic antibiotics (Dibner and Richards, 2005) . With consumer pressure for removal of antibiotics from feeds, alternative, all-natural products to alleviate the depressed performance brought on by a live coccidiosis vaccine have become of increasing interest. Studies have shown that birds exposed to a live coccidiosis vaccine often exhibit reduced feed intake that results in lower growth rates (Paiva et al., 2010) . It has been proposed that the invasion of the intestinal mucosal layer by the live oocysts produce the desired first line of immune C 2017 Poultry Science Association Inc. Received April 27, 2016. Accepted November 16, 2016. 1 Co-first authors 2 Corresponding author: sricke@uark.edu defense (innate immunity), but also an increased localized inflammatory response (Lillhoj, 2014; Niewold, 2014) . Niewold (2014) suggests that the practice of feeding sub-therapeutic levels of antibiotics successfully reduces inflammation and restores optimum appetite and body weight gain following a live coccidiosis vaccination. However, this practice is not available to antibiotic-free or all-natural rearing programs (Van Loo et al., 2012) , and, therefore, finding an all-natural solution that produces similar results is desired.
Research has shown that feeding the fermentation metabolites of Diamond V Original XPC TM (XPC) to turkeys ameliorates the observed reduction in appetite and growth rate following a live coccidiosis vaccination (Paiva et al., 2010) . In that study, turkey hens given a live coccidiosis vaccine exhibited reduced feed intake and decreased body weight gain compared to non-vaccinated controls. Feeding XPC at 1.25 g/kg increased body weight gain of both the non-vaccinated and vaccinated hens, compared to control birds without XPC. In other studies, broilers and laying hens fed XPC and challenged with coccidiosis demonstrated 1831 reduced gastrointestinal damage (occurrence and severity of lesions), increased body weight, and improved feed conversion compared to control challenged birds (Lensing et al., 2012; McIntyre et al., 2013) . In addition, male turkeys fed XPC exhibited a positive effect on breast meat yield and feed efficiency (Firman et al., 2013) . The mechanism that allows XPC to prevent the decrease in growth performance in birds exposed to live coccidiosis is unclear.
Because Salmonella is estimated to cause over 1.0 million illnesses each year, with a significant portion being attributed to poultry and poultry products (Mead et al., 2010; Scallan et al., 2011; Sjölund-Karlsson et al., 2013) , reduction in Salmonella prevalence is of interest to poultry producers in the United States. Previous studies with XPC and products similar in content to XPC have revealed their ability to significantly reduce Salmonella frequency, Campylobacter, and other pathogens as well when cecal contents were evaluated (Line et al., 1998; Lensing et al., 2012; GuyardNicodème et al., 2016) . The mechanism of XPC (and similar products) in pathogen reduction is unclear; however, current hypotheses suggest it is possibly due to the mannan residues binding pathogens, β-glucans stimulating the immune system, and other commensal bacteria improving the tight junction proteins in the intestinal epithelia providing an enhanced intestinal barrier (Spring et al., 2000; Ulluwishewa et al., 2011; Lensing et al., 2012; Firman et al., 2013; Guyard-Nicodème et al., 2016) .
The current study entailed 2 objectives, the first of which was to determine production performance of male broiler chickens challenged with a live coccidiosis vaccine and fed XPC with and without salinomycin (SAL) in the grower feed. The second objective of this study was to determine the effect that inclusion of XPC and/or SAL in the poultry diet had on the Salmonella prevalence.
MATERIALS AND METHODS

Experimental design and husbandry
An experiment was conducted using 1,280 (study birds for growth performance) and 640 (sampling birds The birds were fed a 3-phase feeding program outlined in Table 2 that included starter (zero to 16 d), grower (16 to 28 d), and finisher diets (28 to 42 d). For the birds receiving XPC, the inclusion rate was 1.25 g/kg in the starter and grower diets and reduced to 0.625 g/kg in the finisher diet. The inclusion rate for birds that received SAL in the grower diet was 0.044 g/kg. No additional anti-coccidial or antibiotic products were used in the basal feed of this study prior to treatment with SAL. All diets were pelleted; the starter diets were crumbled after pelleting to accommodate the chicks. Feed and water were provided ad libitum. All birds were vaccinated in the hatchery with Marek's, infectious bursal disease, Newcastle disease, and infectious bronchitis, and sprayed with Coccivac-B (Merck, Kenilworth, NJ) at zero d of age. 
Production performance data collected
All birds were weighed by pen on zero, 16, and 28 d then individually at 42 d when the study ended. Feed intake was measured for all pens for calculations of feed conversion from zero to 16 d, zero to 28 d, and zero to 42 d. Unused feed was weighed, recorded, and subsequently discarded by pen at each feed change. For the entirety of the study, any bird that was found dead or was removed and euthanized was weighed for use in calculating adjusted feed conversion. There were 24 birds randomly selected (3 birds/pen/treatment) chosen for cecal removal at zero, 16, 28, and 42 d of age.
A review by the institutional animal care and use committee (IACUC) was exempt because the birds were raised in an off-campus commercial farm operation and the current study was restricted to microbiological evaluation of birds selected on site. The commercial cooperators used internal animal welfare protocols based on the National Chicken Council (NCC) guidelines (www.nationalchickencouncil.org). Haug et al., 2006) . A sample of feces was soaked in tap water and covered tightly with a lid for 24 h at 4
Oocysts quantification
• C. The sample was shaken vigorously, filtered through a sieve, and the filtrate was centrifuged for the collection of solids. The pelleted material was resuspended in saturated salt solution (NaCl) by gently tapping and inverting the tube. The sample was then transferred to the McMaster Chamber; floating oocysts were enumerated and recorded.
Salmonella isolation and identification
A total of 24 birds was randomly selected (3 birds/pen/treatment) for cecal removal at zero, 16, 28, and 42 d for Salmonella isolation and identification. To determine microbial prevalence, one gram of cecal contents was added to 0.1% peptone water (9 mL) to establish a 1:9 ratio of cecal contents to diluent. Cecal suspensions were enriched in tetrathionate (TT, 9 ml, HIMEDIA, Mumbai, India) broth for 24 h at 37
• C. After incubation, the inoculated TT broth (100 μl) was subsequently streaked on both brilliant green (BG, BD Bioscience, Franklin Lakes, NJ) and xylose-lysinetergitol 4 (XLT-4, BD Bioscience, Franklin Lakes, NJ) agar and grown for 24 h at 37
• C. Colonies suspected of being Salmonella were suspended in 100 μl distilled water for Salmonella confirmation via colony PCR as described in the following section.
A reaction tube (20 μl) contained 2 μl of cell suspension, 10 μl Jump Start Ready Mix (Sigma-Aldrich, St.
Louis, MO), 6 μl of distilled water, and 500 nM of each primer as described in Kim et al. (2006) (F: TTT GGC GGC GCA GGC GAT TC; R: GCC TCC GCC TCA TCA ATC CG). The primers were specific to a transcriptional regulator (STM 3098), 423 bp in length. The PCR was conducted using an initial denaturation step at 94
• C for 5 min, followed by 35 cycles of 94 • C for 30 s, 60
• C for 30 s, and 72
• C for 30 seconds. The elongation step was at 72
• C for 5 min and a final holding step was at 4
• C for 5 minutes. The amplification products (10 μl) were confirmed using 1% gel electrophoresis in 1X Trisacetate-EDTA buffer (1X TAE). The DNA from each of the 39 Salmonella positive colonies was extracted and a multiplex PCR was applied via colony PCR to confirm specific Salmonella serovars according to Park and Ricke (2015) . Positive Salmonella colonies were subsequently run via pulsed field gel electrophoresis (PFGE) and sent to Dr. Steven Foley (National Center for Toxicological Research, FDA, Jefferson, AR) for comparison to a Salmonella serovar reference database of PFGE banding patterns.
Statistical analysis
The JMP R Pro 12 (SAS Institute, Cary, NC) software was utilized for statistical analysis. Broiler performance data were analyzed by the general linear model procedure in JMP and absolute body weight data were transformed to common logarithms prior to analysis. Means separation for broiler performance data was conducted using Tukey-Kramer HSD. One-way analysis of variance (ANOVA) test evaluated the statistical significance among Salmonella prevalence data with a level of significance of P < 0.05.
RESULTS AND DISCUSSION
Production performance
This research was conducted with 2 main objectives. The first was proposed due to the reduced feed consumption that has previously been reported when a live coccidiosis vaccine is used, resulting in lower body weights and poor feed conversion (Williams, 2002; Lee et al., 2011) . This objective was addressed in the current research by determining the feed intake, body weight gain, feed conversion ratio, and the OPG fecal contents in broilers vaccinated with a live coccidiosis vaccine. Feed intake, BW gains, and feed conversion ratios from zero to 16 d, zero to 28 d, and zero to 42 d are presented in Table 3 . The addition of XPC in the diet resulted in a significant increase in feed intake at each feed change in T2 and T4. Improvements in feed intake were apparent as early as 16 d in both T2 and T4 before the inclusion of SAL in the grower diet (16 to 28 d). By 28 d following the use of SAL (0.044 g/kg) in the grower feed, both groups fed XPC (T2 and T4) continued to exhibit increased feed intake over the respective controls (T1 and T3). The addition of XPC appears to be preventing both the suppressed feed intake and increased feed conversion ratio commonly observed among broiler chickens treated with a live coccidiosis vaccine (Williams, 2002; Lee et al., 2011) . This finding is in accordance with McIntyre et al. (2013) . Furthermore, Lensing et al. (2012) reported that XPC fed coccidian-challenged laying hens exhibited less intestinal damages on the occurrence and severity of lesions caused by Eimeria maxima. A similar pattern of improvement was seen for body weight gain for birds fed XPC (Table 3) . At each feed change body weight gain was significantly improved by the addition of XPC with or without the inclusion of SAL in the grower diet compared to the respective controls (T1 and T3). The addition of XPC resulted in significant improvements in body weight gains that were evident as early as 16 d and continued through to 42 days. El-Husseiny et al. (2008) reported similar findings of increased body weight when treating Ross 308 broiler chickens with XPC. Compared to the controls (T1), the addition of XPC to the feed resulted in a significant improvement in cumulative FCR to 28 d in T4 with SAL use in the grower diet (16 to 28 d). The improvements in FCR dissipated after the dose of XPC was reduced to 0.625 g/kg in the finisher diet, suggesting a higher dosage of XPC may be necessary in the finisher diet to maintain the observed improvements observed in FCR. Based on the findings of El-Husseiny et al. (2008), both 0.10 and 0.075% XPC in the diet resulted in increased body weights and reduced FCR at 35 d of age when compared to controls. The current study attempted to determine if a lowered inclusion rate of XPC would be as effective in improving body weights and FCR as the birds reached market age at 42 days. The findings of this study suggest that decreasing the inclusion rate of XPC from 1.25 g/kg to 0.625 g/kg does not support the improved growth performance parameters (body weight gain and FCR) as observed by El-Husseiny et al. (2008) . No significant differences (P > 0.05) were observed in mortality among treatments in this study; the average 42 d mortality for all treatments combined was 4.22%.
Oocyst quantification
Oocysts per gram in fecal samples were highly variable (ranging from 4 to 10,409 OPG), but no significant differences were observed among any of the treatments (Table 4) for any of the ages sampled in this study.
Salmonella prevalence
Colonies suspected to be Salmonella (Table 5 ; 39 total) from selective media were confirmed via multiplex PCR. Salmonella prevalence determined in this study revealed that of the 288 broilers from 16, 28, and 42 d sampling ages, 13.5% of birds tested positive for Salmonella among all treatments. Based on the multiplex primers used, 39 Salmonella isolates were identified to be Salmonella subspecies I specific, yet none of the isolates could be amplified by any of the 3 Salmonella Typhimurium, Heidelberg, or Enteritidis specific primers. Salmonella isolates were further examined by PFGE and compared to a reference database recognizing 38 of the 39 Salmonella isolates to have a close relationship to S. Kentucky based on banding pattern (Figure 1 ). This is in accordance with past surveillance studies conducted; it has been reported that S. Kentucky was the most commonly isolated serovar in 2007, a shift from the previously predominant serovar S. Enteritidis (Foley et al., 2008; CDC, 2013) . While S. Kentucky is often observed in poultry and poultry products, it is not generally regarded as a serovar causing human illness (Foley et al., 2011) .
Broilers receiving XPC appeared to exhibit the lowest Salmonella prevalence at 3.1 and 0.7% for T2 and T4, respectively, while the control treatments (T1 and T3) indicated Salmonella prevalence to be 5.6 and 4.2% respectively. Additionally, T4 revealed significantly lower Salmonella prevalence when compared to both T1 and T2 at 42 d (Figure 2 ). When treatments were statistically compared based on their inclusion of XPC, treatments containing XPC (T2 and T4) resulted in a significantly lower Salmonella prevalence compared to T1 based on selective enrichment (data not shown).
The importance of feed quality in the experimental design of this study had been emphasized to reduce any possibility of contamination in a batch of feed, as that would have caused biased results among treatment groups. Lastly, it is imperative that infection studies with Salmonella marker strains be conducted to quantitate the impact of XPC on Salmonella colonization.
CONCLUSIONS
Prebiotic-like compounds, similar to the XPC fermentation product used in this research, offer promise for the improvement of growth performance, reduction of pathogens, and modulation of the immune system. The current study utilized XPC and SAL to determine their solitary and additive effects on the bird growth performance and the inhibition of Salmonella. Birds treated with XPC revealed increased feed intake and body weight gain, and FCR for T4 was decreased at 28 d in spite of treatment with Coccivac-B. The improvements in FCR dissipated at 42 d, when the inclusion rate of XPC was reduced, supporting the dosage effect of XPC observed in El-Husseiny et al. (2008) . Additionally, the treatments containing XPC revealed lowered levels of Salmonella prevalence. Further research should be conducted evaluating the dosage of XPC in order to continue improved growth performance, as well as the effects of XPC on other commonly encountered foodborne pathogens. Results from this study suggest that XPC could be used in conjunction with a live coccidiosis vaccine to increase growth rate and improve feed conversion of broilers. However, further work is needed to delineate more specific effects directly attributable to XPC. In conclusion, the findings from the current study indicate that XPC may be a viable alternative to antibiotic growth promoters in the poultry industry based on the growth performance effects and the ability to reduce the incidence of Salmonella.
